Glomerular filtration rate in patients with psoriasis treated with etanercept.
作者信息
Gisondi Paolo, Girolomoni Giampiero
机构信息
Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy
Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
出版信息
J Int Med Res. 2016 Sep;44(1 suppl):106-108. doi: 10.1177/0300060515613495.
Abstract
OBJECTIVE
To estimate the prevalence of chronic kidney disease (CKD) and evaluate renal function in patients with moderate-to-severe chronic plaque psoriasis treated with etanercept (an anti-tumour necrosis factor-α drug).
METHODS
This retrospective cohort study included patients with moderate-to-severe chronic plaque psoriasis. Kidney function was evaluated using estimated glomerular filtration rate (EGFR).
RESULTS
The prevalence of CKD at baseline was 3.9% (two of 51 patients). EGFR was unaffected by etanercept therapy (83.6 ± 23.9 at baseline vs 82.2 ± 21.6 ml/min per 1.73 m after 6 months).
CONCLUSION
EGFR was unaffected by 6 months' etanercept treatment. Physicians should be aware of the risk of CKD when providing comprehensive care to patients with moderate-to-severe psoriasis.
摘要
相似文献
1
Glomerular filtration rate in patients with psoriasis treated with etanercept.
J Int Med Res. 2016 Sep;44(1 suppl):106-108. doi: 10.1177/0300060515613495.
2
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Lancet. 2015 Aug 8;386(9993):552-61. doi: 10.1016/S0140-6736(14)62113-9. Epub 2015 Jun 4.
3
Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: a retrospective cohort study.
Eur J Dermatol. 2011 Nov-Dec;21(6):916-20. doi: 10.1684/ejd.2011.1548.
4
Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.
Drug Des Devel Ther. 2015 Oct 12;9:5591-4. doi: 10.2147/DDDT.S87260. eCollection 2015.
5
Evaluation of renal function before and after percutaneous mitral valve repair.
Circ Cardiovasc Interv. 2015 Jan;8(1). doi: 10.1161/CIRCINTERVENTIONS.113.001349.
6
Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
Eur Urol. 2015 Dec;68(6):996-1003. doi: 10.1016/j.eururo.2015.04.043. Epub 2015 May 23.
7
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.
8
Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Int J Chron Obstruct Pulmon Dis. 2015 Jul 6;10:1283-9. doi: 10.2147/COPD.S80673. eCollection 2015.
9
Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes.
Nephrol Dial Transplant. 2008 Feb;23(2):549-55. doi: 10.1093/ndt/gfm857. Epub 2007 Dec 9.
10
Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
HIV Med. 2013 Sep;14(8):503-8. doi: 10.1111/hiv.12038. Epub 2013 Apr 16.
引用本文的文献
1
A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics.
Int J Mol Sci. 2022 Apr 1;23(7):3915. doi: 10.3390/ijms23073915.
2
Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits.
J Clin Aesthet Dermatol. 2019 Jun;12(6):46-54. Epub 2019 Jun 1.
3
Psoriatic Arthritis Is an Indicator of Significant Renal Damage in Patients with Psoriasis: An Observational and Epidemiological Study.
Int J Inflam. 2017;2017:5217687. doi: 10.1155/2017/5217687. Epub 2017 Mar 22.
本文引用的文献
1
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
Arch Dermatol Res. 2015 Dec;307(10):875-83. doi: 10.1007/s00403-015-1593-8. Epub 2015 Sep 10.
2
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.
Br J Dermatol. 2015 Jul;173(1):146-54. doi: 10.1111/bjd.13599. Epub 2015 May 12.
3
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning.
G Ital Dermatol Venereol. 2013 Dec;148(6 Suppl 1):1-10.
4
Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.
BMJ. 2013 Oct 15;347:f5961. doi: 10.1136/bmj.f5961.
5
Estimating glomerular filtration rate: is it good enough? And is it time to move on?
Curr Opin Nephrol Hypertens. 2013 May;22(3):310-5. doi: 10.1097/MNH.0b013e32836041e4.
6
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.
J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e30-41. doi: 10.1111/j.1468-3083.2012.04450.x. Epub 2012 Feb 7.
7
Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis.
J Am Acad Dermatol. 2012 Mar;66(3):369-75. doi: 10.1016/j.jaad.2011.01.022. Epub 2011 Oct 29.
8
Medical comorbidity associated with psoriasis in adults: a population-based study.
Br J Dermatol. 2011 Nov;165(5):1037-43. doi: 10.1111/j.1365-2133.2011.10494.x. Epub 2011 Sep 29.
9
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.
Br J Dermatol. 2010 Sep;163(3):586-92. doi: 10.1111/j.1365-2133.2010.09941.x.
10
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
Br J Dermatol. 2007 Jul;157(1):68-73. doi: 10.1111/j.1365-2133.2007.07986.x. Epub 2007 Jun 6.
Zotero 插件